ScholarLens Back to search
2017•Pharmacological ReportsRequires access

The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats

Aline Zandonadi Lamas, Andrews Marques do Nascimento, Ana Raquel Santos Medeiros, Izabela Facco Caliman, Polyana Lima Meireles Dalpiaz, Luciana Barbosa Firmes, Glauciene Januário de Sousa, Phablo Wendell C. Oliveira, Tadeu Uggere de Andrade, Adelina Martha dos Reis, Sônia Alves Gouvêa, Nazaré Souza Bissoli

Open publisher page 13 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Raloxifene, Selective estrogen receptor modulator, Tamoxifen, Endocrinology, Internal medicine, Estrogen receptor, Estrogen, Atrial natriuretic peptide

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats — Research Paper | ScholarLens